A randomized placebo-controlled trial of traditional Chinese medicine as an add-on therapy to oral montelukast in the treatment of mild persistent asthma in children

详细信息    查看全文

• 作者：Pak-hong Chan ; FHKAM(Paed.)^a ; Ching-yee To ; MNurs^a ; Eric Yat-tung Chan ; FHKAM(Paed.)^a ; Handong Li ; MChinMed^b ; Xiuxia Zhang ; BChinMed^b ; Pok-yu Chow ; FHKAM(Paed.)^a ; Po-ling Liu ; MChinMed^b ; Shuk-yu Leung ; BA^a ; Chung-hong Chan ; MSc^a ; Ka-yan Chan ; MChinMed^b ; Johnny Yick-chun Chan ; FHKAM(Paed.)^a ; Jonathan Pak-heng Ng^a ; Daniel Kwok-keung Ng ; MD^a ; ^{dkkng@ha.org.hk} (Consultant Paediatrician)
• 关键词：AED ; Accident and Emergency Department ; aYPFS ; augmented Yu Ping Feng San ; ACT ; Asthma Control Test ; cACT ; Childhood Asthma Control Test ; CAM ; complementary and alternative medicines ; FEF50 ; forced expiratory flow at 50% of FVC ; FEV1 ; forced expiratory volume in one second ; FEV1/FVC ; ratio between FEV1 and forced vital capacity ; GP ; general practitioner ; ICS ; inhaled corticosteroids ; LTRA ; leukotriene receptor antagonist ; PADQLQ ; Paediatric Allergic Disease Quality of Life Questionnaire ; TCM ; tr
• 刊名：Complementary Therapies in Medicine
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：29
• 期：Complete
• 页码：219-228
• 全文大小：1358 K
• 卷排序：29

文摘

There was significant improvement in ACT™ score in aYPFS group but not in the control group. aYPFS added on to montelukast improved Asthma Control Test Score in children with asthma. There were no significant differences between groups in other primary and secondary outcome parameters.